COVID-19 Reactivates Dormant Viruses Linked to Long COVID, Study Finds
Research published August 15, 2026, shows that COVID-19 infection can wake up viruses hiding in the body, including Epstein-Barr and herpes viruses, with one poorly understood viral family strongly linked to long COVID and lasting disability.
New Discovery on COVID-19 and Dormant Viruses
COVID-19 can reactivate dormant viruses hiding in the body, including Epstein-Barr, cytomegalovirus, and several herpes viruses. This finding offers potential insights into why some COVID-19 patients develop long-term complications.
Link to Long COVID
One poorly understood viral family was strongly associated with long COVID and lasting disability, according to recent research from August 15, 2026. The discovery could help explain the persistent symptoms that affect millions of people who had COVID-19, reshaping how clinicians understand post-viral complications.
Implications for Research and Treatment
The research suggests that the relationship between viral reactivation and long COVID is more complex than previously understood. Understanding which dormant viruses are activated by COVID-19 and how they contribute to persistent symptoms could lead to new diagnostic tools and therapeutic interventions. Scientists are now investigating whether targeting these reactivated viruses could improve outcomes for long COVID patients experiencing fatigue, cognitive dysfunction, and other debilitating symptoms.
What's Next
Further research is needed to clarify the mechanisms by which COVID-19 triggers viral reactivation and to develop clinical strategies to prevent or mitigate these effects. The findings underscore the importance of continued surveillance of post-COVID conditions and expanded investigations into the role of viral co-infections.